Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>Sales increased by 19.8% YoY to JPY589mn, while operating, recurring, and net losses narrowed compared to Q3 FY09/23.</li><li>Gross profit rose 52.4% YoY to JPY107mn; SG&A expenses decreased by 1.2% YoY to JPY1.1bn.</li><li>Specified Cell Products Manufacturing and CDMO businesses saw sales growth, but segment loss widened due to higher sales expenses.</li></ul>

Sales increased by 19.8% YoY to JPY589mn, while operating, recurring, and net losses narrowed compared to Q3 FY09/23.Gross profit rose 52.4% YoY to JPY107mn; SG&A expenses decreased by 1.2% YoY to JPY1.1bn.Specified Cell Products Manufacturing and CDMO businesses saw sales growth, but segment loss widened due to higher sales expenses.

Medinet Co Ltd (2370 JP): Q3 FY09/24 flash update

Japan

MEDINET Co., Ltd. mainly provides facilities, technology, and specialists of immunotherapeutics to medical institutions.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Medinet Co Ltd (2370 JP): Q3 FY09/24 flash update

Sales increased by 19.8% YoY to JPY589mn, while operating, recurring, and net losses narrowed compared to Q3 FY09/23. Gross profit rose 52.4% YoY...

Shared Research